These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 317699)

  • 41. Study of the antitumoral activity of S-carbamoyl-L-cysteine derivatives in animal experiments.
    Németh L; Somfai-Relle S; Kellner B; Sugár J; Bognár R; Farkas J; Bálint J; Pályi I; Tóth K; Szentirmay Z; Somosy Z; Pokorny E
    Arzneimittelforschung; 1978; 28(7):1119-23. PubMed ID: 582699
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adjuvant polyarthritis I: incorporation of quantitative measurements of humoral and cellular immune response.
    Chang YH
    J Pharmacol Exp Ther; 1977 Apr; 201(1):1-7. PubMed ID: 850133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. General pharmacological profile of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N -methylbenzamide.
    Hirohashi M; Takasuna K; Kasai Y; Usui C; Tamura K; Kojima H
    Arzneimittelforschung; 1993 May; 43(5):569-77. PubMed ID: 8329002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunotropic compounds. Structure and biological activity of L-cysteine and 1,3-thiazolidine-4-carboxylic acid derivatives.
    Kwapiszewski W; Ryzewski J
    Arch Immunol Ther Exp (Warsz); 1988; 36(3):239-43. PubMed ID: 3250351
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pharmacological considerations on cetiedil, a drug with prevalent hemodynamic activity].
    Marmo E; Caputi A; Rossi F; Lampa E; Giordano L; Vacca C; Alise G; Somma A; Imperatore A
    Clin Ter; 1979 Jul; 90(1):11-45. PubMed ID: 535327
    [No Abstract]   [Full Text] [Related]  

  • 46. Antianaphylactic and antihistaminic activity of the non-steroidal anti-inflammatory compound nimesulide in guinea-pig.
    Berti F; Rossoni G; Buschi A; Robuschi M; Villa LM
    Arzneimittelforschung; 1990 Sep; 40(9):1011-6. PubMed ID: 1981969
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunological deficiencies induced by some hydrazone derivatives of rifamycin SV.
    Păunescu E
    Rev Roum Med; 1974; 12(4):233-44. PubMed ID: 4617918
    [No Abstract]   [Full Text] [Related]  

  • 48. Plasma proteins -- animal assays on possible cardiovascular side-effects.
    Ronneberger H
    Arch Toxicol Suppl; 1979; (2):509-13. PubMed ID: 288368
    [No Abstract]   [Full Text] [Related]  

  • 49. Immunopharmacologic properties of 1,6-bis[2-(diethylamino)ethoxy]xanthen-9-one dihydrochloride (Wy-15297).
    Rosenthale ME; Santilli AA; Scotese AC; Bell SC; Rubin BA
    J Immunopharmacol; 1980; 2(2):257-77. PubMed ID: 6821553
    [TBL] [Abstract][Full Text] [Related]  

  • 50. On the immunodepressive effect of rifampicin (RFP) on cell-mediated immunity of guniea pigs, examined by rabbit red blood cell rosette formation method.
    Gidoh M; Tsutsumi S
    Nihon Rai Gakkai Zasshi; 1982; 50(2):55-61. PubMed ID: 7161222
    [No Abstract]   [Full Text] [Related]  

  • 51. A new type of cytotoxic immunosuppressive agent: 3-acetyl-5-(4-fluorbenzylidiene)4-hydroxy-2-oxo-2:5-dihydrothiophen.
    Franklin TJ; Newbould BB; O'Mant DM; Scott AI; Stacey GJ; Davies GE
    Nature; 1966 May; 210(5036):638-9. PubMed ID: 5964708
    [No Abstract]   [Full Text] [Related]  

  • 52. [Experimental therapy of adjuvant disease].
    Saratikov AA; Vengerovskiĭ AI
    Farmakol Toksikol; 1983; 46(1):116-20. PubMed ID: 6337869
    [No Abstract]   [Full Text] [Related]  

  • 53. L-cysteine hydrazide--its pharmacological and immunosuppressive activity.
    Ryzewski J; Giełdanowski J; Raberger G; Kossakowska M
    Arch Immunol Ther Exp (Warsz); 1979; 27(6):733-47. PubMed ID: 317699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of the cysteine derivatives on the cell-mediated immunity.
    Ryzewski J; Kossakowska M; Krzystyniak K
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):913-6. PubMed ID: 749839
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological properties of 2,3-dihydro-9H-isoxazolo[3,2-b]-quinazolin-9-one (W-2429. Part 2: General pharmacological investigation.
    Sofia RD; Diamantis W; Gordon R; Edelson J; Ludwig BJ
    Arzneimittelforschung; 1977; 27(4):782-9. PubMed ID: 405977
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmacological study of the new mucolytic drug N-guanyl-cysteine.
    Moratalla R; Romera R; Galiano A
    Arzneimittelforschung; 1986 Jun; 36(6):918-23. PubMed ID: 3488747
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.